Latest News

Coherent is upgraded to a strong buy as accelerating growth, robust demand, and capacity scaling drive a compelling risk/reward profile. The company delivered 34% YoY revenue growth in Q4, beat consen

Rubrik stands out as a compelling cybersecurity play amid heightened AI regulation and macro risks. Recent Q2 results were stellar, with RBRK rebounding nearly 2x from YTD lows and continuing its rall

Vericel's MACI already has an established commercial base, which I think gives them an easier path for future growth. MACI's arthroscopic delivery could also help it expand among surgeons. That's why

Vancouver, British Columbia and Pelly Crossing, Yukon--(Newsfile Corp. - September 14, 2026) - Selkirk Copper Mines Inc. (TSXV: SCMI) (FSE: IO20) (OTCQX: SKRKF) ("Selkirk Copper" or the "Company") is

lululemon reported weak Q2 results, with revenue down 3.2% y/y and core product sales, notably leggings, declining 20%. Operational performance was propped up by one-time tariff refunds; underlying ma

Vancouver, British Columbia--(Newsfile Corp. - September 14, 2026) - Golden Sky Minerals Corp. (TSXV: AUEN) (OTC Pink: LCKYF) ("Golden Sky" or the "Company") is pleased to report results from its spri

Viking Therapeutics NASDAQ: VKTX said its obesity drug candidate VK2735 has advanced into Phase 3 development following Phase 2 results that showed approximately 15% weight loss from baseline after 13

PARSIPPANY-TROY HILLS, N.J., Sept. 14, 2026 /PRNewswire/ -- PBF Energy Inc. (NYSE:PBF) ("PBF Energy") today announced that its indirect subsidiary, PBF Holding Company LLC ("PBF Holding"), priced $500

Low rates of rash, blood clots and administration-related reactions were observed with subcutaneous treatment and prophylaxis Fewer than 1% of patients discontinued treatment due to treatment-related

Oil and 10-year Treasury yields are moving in near lockstep, with their correlation at its strongest since 2019. Higher oil could drive inflation and Treasury yields higher, tightening financial condi

Rose's Income Garden portfolio, spanning 72 holdings, achieved a 12.07% YTD gain and a 5.76% forward yield by August 2026. Flaherty & Crumrine Dynamic Preferred offers an 8% yield, a rising dividend,

Globant remains a compelling buy as Q2 results strengthen the bull case, especially with rapid AI-driven revenue growth and a transformative business model shift. GLOB's new Glob.AI platform and AI Po

Kyverna Therapeutics, Inc. (KYTX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

GraniteShares 2x Long AMD Daily ETF offers leveraged exposure to AMD, targeting 200% of AMD's daily performance. AMD's long-term growth is driven by enterprise AI inference adoption, shifting focus fr

Bloom Energy is rated 'Buy' due to its pivotal role in powering US data centers and accelerating revenue and earnings growth. BE's Q2 2026 results showed 165.5% YoY revenue growth, a 738% EBIT surge,

Enova International, Inc. (ENVA) Discusses Withdrawal of Regulatory Applications for Proposed Bank Acquisition Transcript

Regeneron Pharmaceuticals NASDAQ: REGN outlined growth opportunities for Dupixent, pipeline catalysts for cemdisiran and continued commercial momentum for EYLEA HD during the Morgan Stanley Global Hea

Bank of America Corporation (BAC) Presents at Barclays 24th Annual Global Financial Services Conference Transcript

4D Molecular Therapeutics, Inc. (FDMT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Westrock Coffee is rated buy, supported by robust forward EBITDA growth and an A growth grade from Seeking Alpha Quant. Strong secular demand for ready-to-drink coffee, expanding market share, and ope